ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Radiotherapy for Malignant Astrocytomas in the Elderly

This study has been completed.

Sponsored by: Assistance Publique - Hôpitaux de Paris
Information provided by: Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier: NCT00430911
  Purpose

A randomized trial comparing radiotherapy with supportive care in patients aged 70 years or older with newly diagnosed, histologically confirmed anaplastic astrocytoma or glioblastoma, and a Karnofsky performance status > 70.


Condition Intervention Phase
Primary Brain Tumor
Anaplastic Astrocytoma
Glioblastoma Multiforme
Drug: Radiotherapy
Phase III

MedlinePlus related topics:   Brain Cancer    Cancer   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Pharmacokinetics/Dynamics Study

Further study details as provided by Assistance Publique - Hôpitaux de Paris:

Primary Outcome Measures:
  • Survival

Secondary Outcome Measures:
  • Progression free survival
  • Quality of life
  • Cognitive functions

Study Start Date:   February 2001

  Eligibility
Ages Eligible for Study:   70 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Glioblastoma and anaplastic astrocytoma, supratentorial, histologically confirmed
  • Brain CT scan or MRI within 28 days before surgery
  • Age: 70 years or older
  • Karnofsky performance status, 70 or more.
  • Life expectancy over 12 weeks
  • Informed consent

Exclusion Criteria:

  • Brain radiotherapy
  • Chemotherapy
  • Severe systemic disease
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00430911

Locations
France, Ile de France
Hôpital de la Salpêtrière    
      Paris, Ile de France, France, 75013

Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris

Investigators
Principal Investigator:     jean-yves Delattre, MD     Assistance Publique - Hôpitaux de Paris    
Principal Investigator:     Florence Keime-Guibert, MD     Assitance Publique-Hôpitaux de Paris    
  More Information


Publications indexed to this study:

Study ID Numbers:   PHRC, P000502 AOM 98071
First Received:   January 31, 2007
Last Updated:   January 31, 2007
ClinicalTrials.gov Identifier:   NCT00430911
Health Authority:   France: Ministry of Health

Keywords provided by Assistance Publique - Hôpitaux de Paris:
malignant gliomas  

Study placed in the following topic categories:
Glioblastoma
Malignant astrocytoma
Astrocytoma
Central Nervous System Diseases
Central Nervous System Neoplasms
Brain Diseases
Brain Neoplasms
Neuroectodermal Tumors
Glioblastoma multiforme
Neoplasms, Germ Cell and Embryonal
Neuroepithelioma
Glioma
Nervous System Neoplasms
Neoplasms, Glandular and Epithelial

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site
Neoplasms by Histologic Type
Nervous System Diseases
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial

ClinicalTrials.gov processed this record on November 20, 2008




Links to all studies - primarily for crawlers